Ein Arzt berät einen Patienten (Symbolbild).
Freitag, 19.10.2012 18:05 von | Aufrufe: 180

Fuse Science, Inc. CEO Brian Tuffin and Tiger Woods to Appear on CNBC's "Closing Bell with Maria Bartiromo"

Ein Arzt berät einen Patienten (Symbolbild). © TommL / Vetta / Getty Images https://www.gettyimages.de/

PR Newswire

MIAMI LAKES, Fla., Oct. 19, 2012 /PRNewswire/ -- Fuse Science, Inc. (OTCQB: DROP), (www.fusescience.com) an innovative company that possesses proprietary technologies set to redefine how consumers receive energy, medicines, vitamins and minerals, today announced that CEO Brian Tuffin and Tiger Woods are scheduled to appear together today on CNBC's "Closing Bell with Maria Bartiromo" shortly after 4:00 PM ET.

Mr. Tuffin will be discussing the recent scientific results achieved by Fuse Science that they believe will provide a more efficient way to deliver medicine, nutrients and other actives to the human body.   

About Fuse Science, Inc.

Fuse Science, Inc. (OTCQB: DROP), is an innovative holdings company based in Miami Lakes, Florida.  Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals.  The company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly either through a topical gel roll-on or alternatively in a concentrated "DROP" form that is simply applied under the tongue.  The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products.  Information about Fuse Science is available online at www.fusescience.com and www.poweredbyfuse.com or by calling 305-503-FUSE (3873).

For more information:                                    

To schedule an interview:

Fuse Science, Inc.                                     


ARIVA.DE Börsen-Geflüster

Kurse

0,0118 $
-19,2%
Fuse Science Chart

Gus DeQuesada

Investor Relations                                       

Michelsen Advertising

Direct: (305) 503-3873, Ext. 2                      

C-305-733-1410 / 786-488-7138

Email: ir@fusescience.com                         

prnews@michelsenadvertising.com

Safe Harbor Statement

Certain statements and information included in this release may constitute "forward-looking statements" as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management's projections, estimates and expectations is contained in the Company's SEC filings. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.

SOURCE Fuse Science, Inc.

Werbung

Mehr Nachrichten zur Fuse Science Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News